Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 11.92% is 302% above its 5-year average of -5.90%, near the high end of its 5-year range (-526.41%–46.82%).
1.88% below its 12-month average of 12.15%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 11.16%.
OPERATING MARGIN
11.92%
OPERATING MARGIN AVG TTM
12.15%
OPERATING MARGIN AVG 3Y
0.35%
OPERATING MARGIN AVG 5Y
-5.90%
OPERATING MARGIN AVG 10Y
-0.18%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1.88%
CURRENT VS 3Y AVG
+3281.66%
CURRENT VS 5Y AVG
+301.96%
CURRENT VS 10Y AVG
+6903.73%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 558 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Kiniksa Pharmaceuticals International, plc
Market Cap
$5.79B
Operating Margin
11.92%
TTM Avg
12.15%
3Y Avg
0.35%
5Y Avg
-5.90%
Market Cap
$5.91B
Operating Margin
-4722.13%
TTM Avg
-7394.69%
3Y Avg
-15105.91%
5Y Avg
-12109.07%
Market Cap
$5.57B
Operating Margin
0.53%
TTM Avg
-2.93%
3Y Avg
-2.93%
5Y Avg
-2.93%
Market Cap
$6.12B
Operating Margin
17.61%
TTM Avg
2.04%
3Y Avg
3.68%
5Y Avg
13.44%
Market Cap
$5.36B
Operating Margin
-16191.40%
TTM Avg
-8762.23%
3Y Avg
-42994.83%
5Y Avg
-36872.33%
Market Cap
$6.00B
Operating Margin
-153.08%
TTM Avg
-197.00%
3Y Avg
-9782.25%
5Y Avg
-6521.50%
Market Cap
$5.35B
Operating Margin
29.60%
TTM Avg
36.63%
3Y Avg
34.40%
5Y Avg
32.73%
Market Cap
$5.21B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-174.05%
Market Cap
$5.11B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-101.20%
5Y Avg
-276.55%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | $5.79B | 11.92% | 12.15% | 0.35% | -5.90% |
| CG Oncology Inc. (CGON)vs › | $5.91B | -4722.13% | -7394.69% | -15105.91% | -12109.07% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.57B | 0.53% | -2.93% | -2.93% | -2.93% |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $6.12B | 17.61% | 2.04% | 3.68% | 13.44% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.36B | -16191.40% | -8762.23% | -42994.83% | -36872.33% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $6.00B | -153.08% | -197.00% | -9782.25% | -6521.50% |
| Doximity, Inc. (DOCS)vs › | $5.35B | 29.60% | 36.63% | 34.40% | 32.73% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.21B | 0.00% | 0.00% | 0.00% | -174.05% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.11B | 0.00% | 0.00% | -101.20% | -276.55% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.13B | 12.75% | 11.82% | 10.28% | 7.77% |
Gross Margin
54.5%
Operating Margin
11.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 11.16% |
| 2026-03-31 | 13.66% |
| 2025-12-31 | 9.78% |
| 2025-09-30 | 13.28% |
| 2025-06-30 | 12.86% |
| 2025-03-31 | 9.63% |
| 2024-12-31 | -15.75% |
| 2024-09-30 | -8.61% |
| 2024-06-30 | -0.11% |
| 2024-03-31 | -20.71% |
| 2023-12-31 | 0.10% |
| 2023-09-30 | -16.30% |
| 2023-06-30 | -4.41% |
| 2023-03-31 | -23.16% |
| 2022-12-31 | 9.77% |
| 2022-09-30 | 46.82% |
| 2022-06-30 | -71.81% |
| 2022-03-31 | -72.44% |
| 2021-12-31 | -192.75% |
| 2021-09-30 | -253.55% |
| 2021-06-30 | -526.41% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
